Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bartenstein

Showing results (301-310 of 546) with videos related to

Pageof 55
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|August 31, 2015
Dosimetry for (177)Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancerAndreas Delker, Wolfgang Peter Fendler, Clemens Kratochwil, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2015
Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic geneKerstin Knoop, Nathalie Schwenk, Kathrin Schmohl, et al.
Neurology|January 25, 2013
Functional disturbance of the locomotor network in progressive supranuclear palsyAndreas Zwergal, Christian la Fougère, Stefan Lorenzl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 8, 2012
FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation statusMaximilian Niyazi, Oliver Schnell, Bogdana Suchorska, et al.
Cells|January 31, 2019
Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal ModelsAnne Nack, Matthias Brendel, Julia Nedelcu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 26, 2003
Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivoGerhard Gründer, Ingo Vernaleken, Matthias J Müller, et al.
EJNMMI Research|September 29, 2020
[<sup>18</sup>F]MPPF and [<sup>18</sup>F]FDG μPET imaging in rats: impact of transport and restraint stressVerena Buchecker, Ann-Marie Waldron, R Maarten van Dijk, et al.
Journal of Alzheimer'S Disease : JAD|April 19, 2011
Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's diseaseStefan Förster, Verena C Buschert, Hans-Georg Buchholz, et al.
European Heart Journal. Cardiovascular Imaging|October 1, 2015
FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarctionLisa Gross, Lisa Paintmayer, Sebastian Lehner, et al.
Clinical Nuclear Medicine|August 16, 2020
TSPO PET With 18F-GE-180 to Differentiate Variants of Multiple Sclerosis: Relapsing-Remitting Multiple Sclerosis, Tumefactive Demyelination, and Baló's Concentric SclerosisStefanie Völk, Marcus Unterrainer, Nathalie L Albert, et al.
Pageof 55

Showing results (301-310 of 546) with videos related to

Sort By:
Pageof 55
European Journal of Nuclear Medicine and Molecular Imaging|August 31, 2015
Dosimetry for (177)Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancerAndreas Delker, Wolfgang Peter Fendler, Clemens Kratochwil, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2015
Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic geneKerstin Knoop, Nathalie Schwenk, Kathrin Schmohl, et al.
Neurology|January 25, 2013
Functional disturbance of the locomotor network in progressive supranuclear palsyAndreas Zwergal, Christian la Fougère, Stefan Lorenzl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 8, 2012
FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation statusMaximilian Niyazi, Oliver Schnell, Bogdana Suchorska, et al.
Cells|January 31, 2019
Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal ModelsAnne Nack, Matthias Brendel, Julia Nedelcu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 26, 2003
Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivoGerhard Gründer, Ingo Vernaleken, Matthias J Müller, et al.
EJNMMI Research|September 29, 2020
[<sup>18</sup>F]MPPF and [<sup>18</sup>F]FDG μPET imaging in rats: impact of transport and restraint stressVerena Buchecker, Ann-Marie Waldron, R Maarten van Dijk, et al.
Journal of Alzheimer'S Disease : JAD|April 19, 2011
Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's diseaseStefan Förster, Verena C Buschert, Hans-Georg Buchholz, et al.
European Heart Journal. Cardiovascular Imaging|October 1, 2015
FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarctionLisa Gross, Lisa Paintmayer, Sebastian Lehner, et al.
Clinical Nuclear Medicine|August 16, 2020
TSPO PET With 18F-GE-180 to Differentiate Variants of Multiple Sclerosis: Relapsing-Remitting Multiple Sclerosis, Tumefactive Demyelination, and Baló's Concentric SclerosisStefanie Völk, Marcus Unterrainer, Nathalie L Albert, et al.
Pageof 55